Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Body hormone ghrelin, a food intake and weight gain influence, is found to promote sleep

19.03.2003


New study may have implications for millions in search of the elusive “good night’s sleep”

In movies and novels alike, much is made of the stage of sleep known as rapid eye movement (REM), since this is the phase of slumber in which dreams (good, bad, exotic) occur. Among the medical community, there is an increased appreciation for what is called “slow-wave” sleep, (also known as deep or delta-wave sleep), because this fourth stage of sleep can be difficult to attain. If one is awakened during the first three stages of sleep, they must repeat these stages again before reaching fourth stage or “delta-wave,” sleep.

Once this latter stage is reached, muscles are relaxed, blood pressure drops, and the pulse and breathing are slower. According to the Sleep Research Center, other benefits to the body are accrued during slow-wave sleep, including: an increase of blood supply to the body; a decrease in body temperature thus preserving energy; a lowering of metabolic activity enabling tissue repair and growth; an increase of natural immune-system modulators; and a period in which the growth hormone secretions reach their peak, thus stimulating body growth and development.



A New Study

A team of researchers has found that the peptide hormone ghrelin, bound to the growth hormone secretagogue (GHS) receptor, has a distinct positive action on stage four sleep and nocturnal hormone secretion. Their findings suggest that, in addition to its influence on growth hormone secretion, food intake, and weight gain, ghrelin is a sleep-promoting factor. This new role for the peptide appears to be complementary in function to its established function in the regulation of energy balance and obesity.

Previous rat studies offered conflicting data on sleep following ghrelin administration. In one study, a decrease of REM sleep was found after administration of ghrelin to rats. In another study, ghrelin was given to two different strains of mice, intact animals and those with nonfunctional growth hormone-releasing hormone receptors. Only in mice with intact growth hormone-releasing hormone receptors did NREM sleep increase after administration of the peptide.

Prior to this research, the influence of ghrelin on human sleep was unknown. A team of German researchers selected a protocol that followed previous studies on the sleep-endocrine effects of the peptide, including growth hormone-releasing hormone, GHRP-6, hexarelin, and vasoactive intestinal peptide (VIP). They investigated the effects of the systematic administration of ghrelin on sleep EEG and of GH, ACTH, cortisol, and leptin in healthy male subjects. The authors of “Ghrelin Promotes Slow-Wave Sleep in Humans” are J. C. Weikel, A. Wichniak, M. Ising, H. Brunner, E. Friess, K. Held, S. Mathias, D. A. Schmid, M. Uhr, and A. Steiger, all from the Max Planck Institute of Psychiatry, Department of Psychiatry, Munich, Germany. Their findings appear in the February 2003 edition of the American Journal of Physiology-Endocrinology and Metabolism.

Methodology

Subjects in this study were healthy male volunteers, all free of alcohol, tobacco, and caffeine abuse. The sleep-endocrine studies consisted of two sessions, separated by one week in which a placebo (saline) or ghrelin was administered according to a double-blind, randomized schedule. The experimental sessions consisted of two successive nights in the sleep laboratory. The first night allowed adaptation to the laboratory setting. On the second night, a dose of ghrelin or placebo was administered as a bolus injection through an indwelling intravenous catheter, which permitted administration of the testing drug and repeated blood collection in the adjacent laboratory without disturbing the study subject.

All subjects were reclining at 8:00 PM. Injections of ghrelin or placebo were given hourly between 10:00 PM and 1:00 AM. Blood samples were collected every 30 minutes between 8:00 and 10:00 PM, and every 20 minutes between 10:00 PM and 7:00 AM. The subjects were not allowed to sleep until the lights were turned off at 11:00 PM. Polysomnographic recordings were obtained from 11:00 PM to 7:00 AM, and consisted of two EEGs, vertical and horizontal electroculograms, and electromyogram. A hormone analysis was conducted with the drawn blood samples.

Results

On the night of ghrelin administration, the time spent in slow-wave or stage IV sleep increased significantly compared with the placebo night. Separate inspections of the three sleep-time segments showed significant increases of slow-wave sleep during the first and second thirds of the night but not during the last third. REM sleep showed a significant decrease only during the second third of the night. Intermittent wakefulness appeared to decrease, although it did not reach a level of significance. All other sleep continuity and sleep architecture variables remained unchanged.

Conclusions

This study finds that the body’s endocrine system may offer a means for the body to obtain deep sleep, that which contributes to the body’s overall health. These findings could have important implications for long-term health, since the pursuit of a “good night’s sleep” is an obsession for many Americans.



Source: February 2003 edition of the American Journal of Physiology-Endocrinology and Metabolism.

The American Physiological Society (APS) was founded in 1887 to foster basic and applied science, much of it relating to human health. The Bethesda, MD-based Society has more than 10,000 members and publishes 3,800 articles in its 14 peer-reviewed journals every year.

Donna Krupa | APS
Further information:
http://www.the-aps.org/press_room/journal/pr3-17-2.htm

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>